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j Abstract Background Little is known about late-
onset psychosis (onset after the age 45 years) and how
it relates to early-onset psychosis (before age
45 years). The aims of this study were to calculate the
incidence of non-affective, non-organic psychotic
symptoms across the life span and to explore the
contribution of different sets of risk factors in relation
to age at onset. Methods Data were obtained from the
three measurements of the Netherlands Mental Health
Survey and Incidence Study. Symptoms of psychosis
were assessed in individuals aged 18–64 years using
the Composite International Diagnostic Interview. All
individuals reporting ﬁrst-onset of psychotic symp-
toms within a three-year interval were included. The
degree to which sets of risk factors affected the psy-
chosis outcome similarly across age groups was as-
sessed. Results The number of subjects displaying
incident psychotic symptoms was similar across age
groups. Cumulative incidence rates ranged from 0.3%
to 0.4%. Age differences were found for life-time
depressive symptoms (risk difference = 5%, 95%
CI = 1%, 9%) and baseline neuroticism (risk differ-
ence = 3%, 95% CI = 0%, 6%), indicating that late-
onset psychosis was less often preceded by these. In
contrast, no effect modiﬁcation by age was observed
for female sex, hearing impairment, being single, or
life-time cannabis use. Conclusions Onset of psy-
chotic symptoms in late life is no rare event. Com-
pared to early onset psychosis, the late-onset
counterpart less often arises in a context of emotional
dysfunction and negative affectivity, suggesting
qualitative differences in aetiology and more effective
premorbid coping styles.
j Key words psychosis – late onset – risk factors –
incidence – general population
Introduction
Schizophrenia and related non-affective, non-organic
psychotic disorders have predominantly been studied
in adolescence and young adulthood (early-onset psy-
chosis, EOP). Some individuals, however, experience
psychotic symptoms for the ﬁrst time after the age of
40 years (late-onset psychosis, LOP) [19, 29]. In LOP,
theclinicalpictureisdominatedbyhallucinationsinall
modalities and systematic delusions that concern the
patient’s personal space and security like paranoid
delusions or partition delusions [8, 26, 27], while dis-
organized and negative symptoms are uncommon [44,
53].In45%ofsubjects,theonsetofLOPis precededby
a history of paranoid or schizotypic personality styles
[31, 33, 45] which raises the question whether these
cases constitute a group of schizophrenia with delayed
expression of a latent disorder rather than truly late
onset of a disorder de novo.
j Incidence rates
Studies of ﬁrst admission rates over the last four
decades have consistently found low incidence rates
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dence of 3.0 per 100,000 for DSM-III-R schizophrenia
and 16.6 per 100,000 for delusional disorder in those
aged 65 years and over [11]. Castle and Murray,
applying the same criteria, calculated a rate of 12.6
per 100,000 person-years [9]. Using the broader
concept of late paraphrenia, Kay estimated the annual
rate for those aged 55 years and older to be 10–15 per
100,000 for males and 20–25 per 100,000 for females
[32]. In the general population aged 60 years or older,
Van Os et al. showed an 11% increase in ﬁrst
admission rates for ICD-9 schizophrenia, paraphre-
nia, paranoid states and other non-affective, non-or-
ganic psychosis for each 5 year increase in age [64].
Incidence rates rose from 10 per 100,000 person-years
in those aged 65 years to 19 per 100,000 in those aged
75 with further progression to 25 per 100,000 in the
90+ age group. Ha ¨fner et al. found an annual inci-
dence rate of 13 per 100,000 for broadly deﬁned
schizophrenia-spectrum disorders within the age
range of 50–59 years [18].
These ﬁgures match well with those reported for
schizophrenia [20, 51]. Service-based studies, how-
ever, are likely to underestimate the frequency of the
disorder, and community surveys independent of
service use generally ﬁnd higher rates, but researchers
have been reluctant to carry out such studies with
LOP [68]. Methodological obstacles in conjunction
with the supposed infrequency of the disorder may
explain this. For example, a diagnosis of LOP is dif-
ﬁcult to make using lay interviews. Hence, an alter-
native approach is to collect data on the basis of
presence of single functional psychotic symptoms
without focussing on diagnostic categories. Using this
strategy, Christenson and Blazer identiﬁed prevalent
paranoid ideation in 4% of a sample of community
living elderly [10]. Similar ﬁgures have been found
among the non-institutionalized cognitively intact
elderly [24], with prevalence rates as high as 10%
among the non-demented very old (older than
84 years) [43]. Prevalence rates, however, cannot
distinguish between persistence of psychosis with an
early onset and psychosis with a true onset in old age.
j Risk factors
If LOP constitutes a separate phenotype within the
schizophrenia spectrum, it is attractive to hypothesize
that there will be quantitative or qualitative differ-
ences between LOP and EOP with respect to risk
factors associated with psychosis such as cannabis use
[3, 25, 66], childhood trauma [30, 36], urbanisation
[57, 58, 65], schizoid and paranoid premorbid per-
sonality [14], neuroticism [24, 34], depressive and
other affective symptoms [35, 69] or social isolation
[50]. Among the list of putative risk factors for LOP,
female sex presents itself as the most prominent one,
with women running a two to six times greater risk
than men [9, 18, 54], especially if only paranoid states
are considered [1, 52]. It seems that men consume
their lifetime risk more rapidly than women and are
thus hardly found in late-onset pools [20]. A protec-
tive role for female sexual hormones in LOP has hence
been suggested, as estrogens may decrease the risk in
pre-menopausal women by virtue of their antidop-
aminergic effects [13, 18, 39, 55]. Another hypothe-
sized age-related risk factor may be hearing
impairment, particularly in patients aged 60 years
and older [28, 46, 50, 62], although recent work sug-
gests the effect of hearing impairment is not age
speciﬁc [61].
j Research questions and hypotheses
The present study calculates incidence rates for psy-
chosis as a function of age in the general population
of the Netherlands. It was hypothesized that onset of
functional psychosis occurs less often in old age than
in young and middle age. Second, possible effect
modiﬁcation by age of sets of known risk factors for
psychosis was assessed, such as depression, neuroti-
cism, urbanisation, cannabis use, sex, sensory
impairment and family history of psychosis.
Method
j Sample
This study made use of the data from the Netherlands Mental
Health Survey and Incidence Study (NEMESIS), a longitudinal
study of the prevalence, incidence, course and consequences of
psychiatric disorders in the Dutch general population [5, 6, 16]. The
study consists of three measurement points with a total duration of
three years: at baseline (hereafter: T0), 1 year thereafter (hereafter:
T1) and again 2 years after T1 (hereafter: T2). Participants were
identiﬁed by means of a multistage, stratiﬁed, random sampling
procedure in which 90 municipalities were sampled randomly. In a
second step, random selections of addresses from private house-
holds were made. Thirdly, the person with the most recent birthday
at the moment of selection and aged between 18 years and 64 years
received an introductory letter form the Minister of Health. Not
included were institutionalized individuals. At baseline, 7,076
subjects participated, which is a response rate of 69.7%. According
to the General Health Questionnaire, 12 items (GHQ-12) [17]
responders and non-responders did not differ with respect to
psychiatric morbidity [5, 6]. At T1, 5,618 subjects (79%) partici-
pated, at T2, 4,848 subjects (69%) participated. The local ethics
committee approved the study proposal.
j Instruments
At T0 to T2, the Composite International Diagnostic Interview
(CIDI) version 1.1 [56] was administered at home. The CIDI is a
structured interview and is designed for the use by trained inter-
viewers who are not clinicians. It has satisfactory inter-rater reli-
ability [12] and test–retest reliability [67]. Ninety interviewers
experienced in systematic data collection administered the inter-
view after having received intensive training. In order to assess
psychotic symptoms, ratings from the CIDI core psychosis section
on delusions (13 items) and hallucinations (4 items) were used
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chotic symptoms involving, for example, thought interference and
passivity phenomena, persecution and auditory hallucinations. All
these items can be rated in six ways: ‘1’, no symptom; ‘2’, symptom
present but not clinically relevant (not bothered by it and not
seeking help for it); ‘3’, symptom result of ingestion of drugs/
medication; ‘4’, symptom result of a somatic disease; ‘5’, true
psychiatric symptom causing distress or help-seeking behaviour;
‘6’, symptom may not really be a symptom because there appears to
be some plausible explanation for it. In order to verify symptom
presence and their clinical relevance, clinical re-interviews were
conducted over the telephone by a senior registrar in psychiatry for
all individuals who had at least one rating of 5 or 6, using single
questions from the Structural Clinical Interview for DSM-III-R
(SCID), an instrument with proven reliability and validity in
diagnosing schizophrenia [59]. CIDI ratings of ‘5’ and ‘6’ were
corrected on the basis of these clinical interviews. Life-time
depression was assessed using the 28 items of the CIDI core
depression section (E) with exclusion of four items related to
dysthymia. Life-time mania was assessed using the 11 items of the
CIDI core mania section (F). All these items can be rated as either
‘yes’ (1) or ‘no’ (0). Symptoms of depression (e.g., anhedonia) had
to be present for at least 2 weeks, manic symptoms (e.g., persis-
tently elevated, expansive or irritable mood) had to be present for
at least two days. In order to make a DSM-III-R diagnoses, the CIDI
assesses whether the mood symptoms and other symptoms were
present within the same time period [48]. Neuroticism was assessed
at baseline with the 14-item Groningen Neuroticism Scale [42].
Family history of depression and psychosis was examined at T1, by
asking the subject whether any of his ﬁrst degree biological rela-
tives had ever experienced depressive symptoms and/or delusions
or hallucinations, providing descriptions of these. Family history of
treated depression and psychosis was examined at T1, by asking the
subject whether the affected ﬁrst degree biological relatives had
ever received medical or psychological help for these symptoms.
Urbanicity was coded as rural if a municipality had fewer than 500
addresses per square kilometre and urban otherwise. Single living
status was assessed by asking the subject whether or not he per-
manently shares a household with someone else, irrespective of
ownership. Visual or auditory impairment was scored as present if
respondents self-reported such a condition being treated or mon-
itored by a physician in the 12 months before T0.
j Statistical analysis
For the current investigation, two outcome measures were created.
First, all subjects with broadly deﬁned psychosis-like experiences
(CIDI ratings of ‘2’, ‘3’, ‘4’, ‘5’ and ‘6’) at T1 or T2 were included in
the analyses if they had not displayed such symptoms at T0
(hereafter: broad psychosis outcome). This outcome was rated as
either present (=‘1’) or absent (=‘0’). For the second outcome, only
subjects who reported narrowly deﬁned clinically relevant psy-
chotic symptoms (CIDI ratings of ‘5’) were included if they had had
no evidence of psychosis at T0 (hereafter: narrow psychosis out-
come). This outcome was similarly scored as either present (=‘1’)
or absent (=‘0’). Subjects were then divided into three age groups of
young (18–34 years), middle (35–49 years) and old age (50–
64 years). Contrasts were expected to show up most powerfully in
the comparisons between the youngest and oldest age groups, thus
the analysis has this contrast as its focus. In order to test for
contributions of different sets of risk factors to the psychosis
outcome, a general linear modelling (GLM) strategy was applied.
Interaction effects were analysed using the BINREG procedure in
STATA [60], a GLM extension for the binomial family. Interaction
effects between age group and categorical or dummy coded expo-
sure variables were estimated under an additive model [15] yielding
risk difference effect sizes. Cumulative incidences of psychosis
outcome at T1 and/or T2 were calculated in subjects with absence
of the narrow psychosis outcome at baseline (risk set: n = 4,637)
and in subjects with absence of the broad psychosis outcome (risk
set: n = 4,041). Cumulative incidence rates across age groups were
compared by means of Pearson v
2 tests. A post-hoc analysis was
performed for ﬁrst contact rates. All data were analysed using the
STATA program, version 9.1 [60].
Results
Table 1 lists the demographic characteristics of the
sample participating in the follow-up at T1 and/or T2.
No differences existed for urbanicity (v
2 = 3.78,
df = 2, p = .151) across groups. Differences emerged
for level of education (v
2 = 44.14, df = 2, p < .001),
single living status (v
2 = 1300, df = 2, p < .001), and
visual and auditory impairment (v
2 = 19.47, df = 2,
p < .001andv
2 = 24.34,df = 2,p < .001,respectively)
with older subjects having had less higher education
than the young and the middle group, living alone
more often and reporting sensory impairment more
often.Themale:femaleratioalsodifferedacrossgroups
with women being somewhat overrepresented in the
young and old group (v
2 = 10.92, df = 2, p = .004).
j Cumulative incidence
At T1 or T2, 56 out of 4,637 individuals with no psy-
chosis at baseline had the narrow psychosis outcome.
Of all these incident psychosis, 19 were in the young
group (34%), 25 in the middle group (44%) and 12 in
the old group (21%). The cumulative incidence of LOP
was 0.3%. This rate was comparable to the cumulative
incidence rate of EOP (0.4%) and MOP (0.4%)
(v
2 = 1.19, df = 2, p = .55). Out of 4,401 subjects
without any self-reported psychotic experiences in the
past, 132 had developed the broad psychosis outcome
at T1 or T2. Fifty-one of these were in the young group
(38%), 54 were in the middle group (42%) and 27
(20%) were in the old group. The cumulative incidence
for the broad psychosis outcome was 0.8% in the old
group, 1.3% in the young group and 1.1% in the
middle group (v
2 = 4.66, df = 2, p = .097).
Table 1 Characteristics of the NEMESIS sample at the one-year follow-up
measure
Age groups (%)
Young Middle Old Total sample
Mean age 27.7 41.6 56.7 41.2
Female sex 55.6 50.8 54.7 53.5
Education (in years)
0–11 17.1 25.2 37.0 25.7
12 40.4 35.8 33.1 36.6
13–15 9.2 7.3 5.9 7.6
16+ 32.3 30.7 22.3 28.9
Single 56.4 14.9 6.2 26.5
Urban 83.4 81.4 83.4 82.6
Sensory deficits
Hearing impairment 1.4 2.2 3.9 2.4
Visual impairment 0.7 1.2 2.5 1.4
Total number 1,891 2,198 1,527 5,616
290j Risk factors
Age effect modification
Main effects of risk factors on the broad psychosis
outcome in NEMESIS have been described in other
reports [4, 21, 30, 34, 35, 62, 66]. Signiﬁcant interac-
tions with age at onset were found for depression
(Risk difference = )2.2%, 95% CI = )4.1%, )0.3%)
and family history (FH) of treated delusions/halluci-
nations (RD = 3.3%, 95% CI = 0.3%, 6.2%), suggest-
ing that the effects of both varied across age groups.
The negligible prevalence, however, of FH treated
delusions/ hallucinations in those having the broad
psychosis outcome made further analysis impracti-
cable (n = 3, all in the middle group). Statistical
trends for interaction were observed for sex
(RD = )1.3%, 95% CI = )0.8%, 2.7%), neuroticism
(RD = )1.5%, 95% CI = )3.1%, 0.1%) and hearing
impairment (RD = )5.9%, 95% CI = )12.1%, 0.2%).
For the latter, the prevalence was too small to carry
out stratiﬁed analyses, leaving depression, neuroti-
cism and sex as targets for further analyses.
Age at onset and depression
Stratiﬁed comparisons (Table 2) demonstrated that
baseline depressive symptoms signiﬁcantly increased
the risk for developing the broad psychosis outcome
within a three-year interval in the young (RD = 6.5%,
95% CI = 3.3%, 9.7%) and middle group (RD = 2.5%,
95% CI = 0.4%, 4.7%), but not in the old group
(RD = 1.7%, 95% CI = )0.7%, 4.1%) (Table 2). In the
youngest group, 8.8% of those reporting life-time
depressive symptoms at baseline had the broad psy-
chosis outcome 3 years later as opposed to 2.3% of
those reporting no depressive symptoms. In the old
group, 3.7% of those reporting life-time depressive
symptoms developed the broad psychosis outcome as
opposed to 2.0% of those reporting no depressive
symptoms. The absolute RD between the young and
the old group was signiﬁcant (RD = 4.8%, 95%
CI = 0.8%, 8.8%). Thus, the risk-increasing effect of
depression declined by a factor of 3.8 (6.5% / 1.7%)
with age at onset.
Age at onset and neuroticism
A signiﬁcant risk-increasing effect of neuroticism
was observed for the young (RD = 5.3%, 95%
CI = 2.7%, 7.9%), middle (RD = 2.8%, 95%
CI = 0.8%, 4.9%) and old group (RD = 2.2%, 95%
CI = 0.2%, 4.2%). In the young group, 7.4% of those
with high neuroticism scores at baseline developed
the broad psychosis outcome, versus 2.1% of those
with low neuroticism scores. These ﬁgures dropped
to 5.2 % vs. 2.4% in middle age with further pro-
gression to 3.8% vs. 1.5% in old age. The absolute
RD between the young and the old group, however,
did not reach signiﬁcance (RD = 3.1%, 95%
CI = )0.2%, 6.4%). Thus, the risk increasing effect
of neuroticism declined by a factor of 2.4 (5.3%/
2.2%) with age at onset.
Age at onset and sex
The overall interaction between sex and age showed a
trend towards signiﬁcance, but no clear effect was
apparent after stratiﬁcation for age at onset. No
greater risk for female sex was found in the young
(RD = 1.7%, 95% CI = )0.4%, 3.7%), the middle
(RD = 0.4%, 95% CI = )1.4%, 2.1%) or the old group
(RD = )0.9%, 95% CI = )2.7%, 0.9%).
Discussion
j Incidence
With an annual incidence of 0.3%, the community
rate for (clinically relevant, but mostly untreated)
non-affective, non-organic psychotic symptoms with
late-onset was twenty times higher than the rate of
treated clinical disorders reported previously [9, 11,
18, 32, 64]. Of all new ‘‘cases’’, 21% were over 50 years
of age at illness onset, which is in line with previous
ﬁndings [27, 31]. Similar disparities between clinical
and community levels have been published with re-
gard to prevalence rates of psychotic symptoms
among the cognitively intact old [10, 24] and very old
[43]. Psychosis in old age seems much more common
Table 2 Risk increasing effect of the
risk factors life-time depression and
high neuroticism on the broad
psychosis outcome for those with
onset of first psychotic symptoms in
young age (18–34 years), middle age
(35–49 years) and old age (50–
64 years)
Risk factor
Age at onset Yes No Risk differences 95% CI
Depression Young 8.8% 2.3% 6.5% 3.3%, 9.7%
Middle 5.1% 2.5% 2.5% 0.4%, 4.7%
Old 3.7% 2.0% 1.7% )0.7%, 4.1%
Neuroticism Young 7.4% 2.1% 5.3% 2.9%, 10%
Middle 5.2% 2.4% 2.8% 0.8%, 5%
Old 3.8% 1.5% 2.2% 0.2%, 4.2%
Effect sizes are expressed as risk differences between those who had the risk factor and later on developed the psychosis
outcome (yes) and those who did not have the risk factor but still developed the psychosis outcome (no).
291than previously thought [7] and so does psychosis
with late onset. The high incidence rate of psychotic
symptoms as opposed to clinical disorder may not
only be due to the fact that most of the sample with
isolated psychotic symptoms would not have clinical
needs, but may also be related to the argument that
paranoid elderly often do not seek help [10, 47], and
LOP, therefore, tends to be associated with longer
community stays [49]. This lack of help-seeking
behaviour may, in turn, be a direct reﬂection of per-
secutory ideation, illness behaviour or of social iso-
lation in old age [49, 68]. In a post-hoc analysis for
those with the broad psychosis outcome, however, we
were unable to ﬁnd any differences in ﬁrst-contact
rates as a function of age at onset (young versus
middle: v
2 = .61, df = 1, p = .435; young versus old:
v
2 = .08, df = 1, p = .777; middle versus old: v
2 = .14,
df = 1, p = .708).
It has to be noted that cell sizes for new psychosis
were rather small and decreased even further by
stratiﬁcation for age groups. Hence, only 12 subjects
out of 1,282 aged 50–64 years developed a recent-
onset psychosis in the present study. This number
may be considered too small to calculate reliable
incidence rates. This ﬁnding, therefore, calls for rep-
lication, but echoes similar ﬁndings in the younger
age groups [22].
j Risk factors
Symptoms of depression and neurotic personality
styles were found to have some association with age at
onset. In young age, subjects reporting life-time
depressive symptoms at baseline run a higher risk of
developing psychotic experiences later on than those
who do not report depressive symptoms. The risk-
enhancing effect in young age decreased to a much
lower level in middle and old age. Although effect
sizes did not reach signiﬁcance in those aged 50–64, a
history of depressive symptoms went together with a
two-fold increase in psychosis risk, which suggests
that signiﬁcance may have been reached with bigger
cell sizes. Depression is known to be a common
antecedent of psychosis in general [35, 69] and in late
life [24], but it now seems that the strength of this
relationship diminishes as the illness onset shifts to-
wards later ages, pointing towards aetiological dif-
ferences between LOP en EOP. This observation very
nicely ﬁts the repeated ﬁnding of less emotional co-
morbidity in LOP [31, 38, 49, 63].
In a similar fashion, the risk-enhancing effect of
neuroticism has been studied previously [34], but its
association with psychosis appears to be less strong
with onset in old age [23]. Ha ¨fner et al. found that,
although the severity of psychopathology decreased
with age at ﬁrst episode, this was not caused by a
decrease in the severity of psychotic symptoms but by
a decrease in neurotic syndrome levels [18]. Neurot-
icism is a personality trait related to stress reactivity,
anxiety proneness and emotional instability in the
context of daily stressors [40, 42]. In schizophrenic
patients, high neuroticism levels are associated with
avoidant coping styles and emotional discomfort [37],
which might indicate that the diminishing effect of
neuroticism in LOP reﬂects more adaptive coping
skills in later adulthood. This lends further support to
the notion of possible aetiological differences with
psychosis in young age.
Men and women run an equal risk for LOP in the
present study, which is at odds with earlier ﬁndings,
but in line with the community-based study by Hen-
derson and colleagues [24]. The authors explain their
resultbythehigherrefusalofwomentotakepartinthe
study. This does not apply to NEMESIS. Alternatively,
it may be that older men are less likely to come to
professionalattentionandareforthisreasonmissedin
clinical studies. Although being highly speculative, it is
compatible with the notion of profoundly lower
symptomlevelsinmaleswithLOP[18].Unfortunately,
we were unable to explore this issue in depth.
Sensory impairment was not found to increase the
risk for psychosis in later life. The outcome measures
of deafness and visual impairment appeared to be too
stringent. In addition, the sample may have been too
young for these variables to exert signiﬁcant effects.
Only two out of 132 subjects with recent-onset psy-
chotic symptoms suffered from severe visual deﬁcits
and four reported severe auditory deﬁcits. All were
younger than 50 years.
No notable differences in risk proﬁles between
groups were found for level of urbanisation, life-time
cannabis use, life-time manic symptoms, family his-
tory of psychiatric treatment, family history of psy-
chosis or single living status.
j Limitations
Regrettably, NEMESIS does not provide information
for those older than 64 years. One may expect
(qualitative) differences in risk proﬁles with EOP to
show up more profoundly in those aged 65 years and
older including cognitive ageing, sensory loss, death
of a spouse or retirement [2, 28, 29].
The reported differences between LOP and EOP
might be considered an underestimation of true risk
differences, because analyses of risk factors was based
on the broad psychosis outcome. It has been shown
previously that this outcome results in smaller effect
sizes than narrowly deﬁned psychosis [22, 41].
Further limitations include the use of lay inter-
viewers and difﬁculties in excluding psychosis due to
prodromal dementia. Although the CIDI is designed
for the use by non-clinicians and interviewers
underwent intensive training, these well-known
problems cannot be completely solved in studies of
this kind [68]. They were nevertheless minimized by
292conducting re-interviews by an experienced psychia-
trist to ascertain clinical relevance of psychotic
symptoms using questions from the SCID.
Conclusion
This study fuels the ﬁnding that non-affective, non-
organic psychotic symptoms arise more often in the
second half of life than studies on a syndromal level
have implied. LOP is less likely to be preceded by
neuroticism and emotional disturbances, which sug-
gests that those affected have learned to use more
effective coping styles in daily life. Yet, the similarities
in risk proﬁles across different ages at onset outweigh
the differences.
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